We present a 42-year-old woman with no history of diabetes or glucose intolerance who had a 5-year history of ulcerative necrobiosis lipoidica (NL). Despite failure of multiple medications, she experienced clearing of her ulcers after her treatment was changed to ustekinumab. We discuss our patient’s disease course and elaborate upon mechanistic reasons for her improvement related to ustekinumab therapy.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2eDYLYk
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: June 2017 Source: Anesthesiology Clinics, Volume 35, Issue 2 Author(s): Anair Beverly, Alan D. Kaye, Olle Ljungqvist, R...
-
At the King’s Fund’s annual conference on leadership and management last week, NHS England’s chief executive, Simon Stevens, found an innova...
-
Abstract Kimchi was prepared with different types of salts: purified salt (PS), solar salt aged for 1 year (SS1), aged for 3 years (SS3), a...
-
Abstract Although Nobori ® , with a bioresorbable polymer and biolimus A9 abluminal coating, has unique characteristics, few data exist re...
-
http://ift.tt/2rdV14q
-
Abstract In this study we investigated whether exerting an impulse on a Chronic Total Occlusion (CTO) improves the success rate of CTO cro...
-
Zusammenfassung Nichtmelanozytärer Hautkrebs und seine Frühformen sind aufgrund von steigender Inzidenz und Prävalenz häufige Diagnosen im...
-
2016-10-05T05-46-18Z Source: International Journal of Research in Medical Sciences Noha Seada, Mostafa G. M. Mostafa. Background: Heart...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου